http://purl.org/np/RAZW8rLrF4... RAZW8rLrF4

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

https://dailymed.nlm.nih.gov/d...37-848b-45fd-9107-a6db5a675360 drugInfo.cfm?setid=5b8fb137-848b-45fd-9107-a6db5a675360

Sarah Chenine

2021-04-04T19:36:27.877Z

http://purl.org/np/RAZW8rLrF4... RAZW8rLrF4

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/ns/prov#value value

Vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss

Sarah Chenine

2021-04-04T19:36:27.877Z

http://purl.org/np/RAZW8rLrF4... RAZW8rLrF4

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://purl.org/np/RAZW8rLrF4...#medtherapy medtherapy

http://www.w3.org/ns/prov#wasDerivedFrom wasDerivedFrom

Sarah Chenine

2021-04-04T19:36:27.877Z